A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients.

Imogen Mitchell, Emma Knight, Jelena Gissane, Rohit Tamhane, Rao Kolli, I. Anne Leditschke, Rinaldo Bellomo, Simon Finfer

Research output: Contribution to journalArticleResearchpeer-review

36 Citations (Scopus)

Abstract

OBJECTIVE: To determine the safety and efficacy of an intensive insulin regimen compared with a conventional insulin regimen in general intensive care unit patients. METHODS: A phase II, randomised controlled trial was conducted in 70 critically ill patients in a closed multidisciplinary ICU of a university-affiliated tertiary hospital. We assessed patient characteristics at baseline. Trial process measures included number of blood glucose measurements per day and number in target range, type and quantity of caloric intake, patient outcome and insulin dosing. The primary outcome was the median blood glucose concentration. Secondary outcome measures were incidence of hypoglycaemia (blood glucose level < 2.2 mmol/L), clinical sequelae of hypoglycaemia and hospital mortality. RESULTS: Thirty-five patients were randomised to each of the two groups. More blood glucose samples were taken per day in the intensive insulin group (16 versus 9), but the number of samples in the normoglycaemic range was 48.5%, compared with 79.8% within the target glucose range in the conventional insulin group. The median (interquartile range) blood glucose concentrations in the intensive and conventional insulin therapy groups were 5.4 (5.1-5.7) mmol/L and 7.9 (7.2-9.0) mmol/L, respectively (difference, 2.5 mmol/L; P < 0.0001). Five patients (14.3%) in the intensive insulin therapy group became hypoglycaemic versus none in the conventional insulin therapy group. There were no detected clinical sequelae of hypoglycaemia. CONCLUSION: The intensive insulin regimen was effective in achieving the target blood glucose concentration, with clear separation from the conventional insulin regimen. Although the incidence of hypoglycaemia was increased, there was no detectable harm.

Original languageEnglish
Pages (from-to)289-293
Number of pages5
JournalCritical Care and Resuscitation
Volume8
Issue number4
Publication statusPublished - 1 Jan 2006
Externally publishedYes

Cite this

Mitchell, I., Knight, E., Gissane, J., Tamhane, R., Kolli, R., Leditschke, I. A., ... Finfer, S. (2006). A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients. Critical Care and Resuscitation, 8(4), 289-293.
Mitchell, Imogen ; Knight, Emma ; Gissane, Jelena ; Tamhane, Rohit ; Kolli, Rao ; Leditschke, I. Anne ; Bellomo, Rinaldo ; Finfer, Simon. / A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients. In: Critical Care and Resuscitation. 2006 ; Vol. 8, No. 4. pp. 289-293.
@article{9edb35eb3dff4bd58d0538e67c741391,
title = "A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients.",
abstract = "OBJECTIVE: To determine the safety and efficacy of an intensive insulin regimen compared with a conventional insulin regimen in general intensive care unit patients. METHODS: A phase II, randomised controlled trial was conducted in 70 critically ill patients in a closed multidisciplinary ICU of a university-affiliated tertiary hospital. We assessed patient characteristics at baseline. Trial process measures included number of blood glucose measurements per day and number in target range, type and quantity of caloric intake, patient outcome and insulin dosing. The primary outcome was the median blood glucose concentration. Secondary outcome measures were incidence of hypoglycaemia (blood glucose level < 2.2 mmol/L), clinical sequelae of hypoglycaemia and hospital mortality. RESULTS: Thirty-five patients were randomised to each of the two groups. More blood glucose samples were taken per day in the intensive insulin group (16 versus 9), but the number of samples in the normoglycaemic range was 48.5{\%}, compared with 79.8{\%} within the target glucose range in the conventional insulin group. The median (interquartile range) blood glucose concentrations in the intensive and conventional insulin therapy groups were 5.4 (5.1-5.7) mmol/L and 7.9 (7.2-9.0) mmol/L, respectively (difference, 2.5 mmol/L; P < 0.0001). Five patients (14.3{\%}) in the intensive insulin therapy group became hypoglycaemic versus none in the conventional insulin therapy group. There were no detected clinical sequelae of hypoglycaemia. CONCLUSION: The intensive insulin regimen was effective in achieving the target blood glucose concentration, with clear separation from the conventional insulin regimen. Although the incidence of hypoglycaemia was increased, there was no detectable harm.",
author = "Imogen Mitchell and Emma Knight and Jelena Gissane and Rohit Tamhane and Rao Kolli and Leditschke, {I. Anne} and Rinaldo Bellomo and Simon Finfer",
year = "2006",
month = "1",
day = "1",
language = "English",
volume = "8",
pages = "289--293",
journal = "Critical Care and Resuscitation",
issn = "1441-2772",
publisher = "Australasian Medical Publishing Co. Pty Ltd. (AMPCo)",
number = "4",

}

Mitchell, I, Knight, E, Gissane, J, Tamhane, R, Kolli, R, Leditschke, IA, Bellomo, R & Finfer, S 2006, 'A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients.', Critical Care and Resuscitation, vol. 8, no. 4, pp. 289-293.

A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients. / Mitchell, Imogen; Knight, Emma; Gissane, Jelena; Tamhane, Rohit; Kolli, Rao; Leditschke, I. Anne; Bellomo, Rinaldo; Finfer, Simon.

In: Critical Care and Resuscitation, Vol. 8, No. 4, 01.01.2006, p. 289-293.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients.

AU - Mitchell, Imogen

AU - Knight, Emma

AU - Gissane, Jelena

AU - Tamhane, Rohit

AU - Kolli, Rao

AU - Leditschke, I. Anne

AU - Bellomo, Rinaldo

AU - Finfer, Simon

PY - 2006/1/1

Y1 - 2006/1/1

N2 - OBJECTIVE: To determine the safety and efficacy of an intensive insulin regimen compared with a conventional insulin regimen in general intensive care unit patients. METHODS: A phase II, randomised controlled trial was conducted in 70 critically ill patients in a closed multidisciplinary ICU of a university-affiliated tertiary hospital. We assessed patient characteristics at baseline. Trial process measures included number of blood glucose measurements per day and number in target range, type and quantity of caloric intake, patient outcome and insulin dosing. The primary outcome was the median blood glucose concentration. Secondary outcome measures were incidence of hypoglycaemia (blood glucose level < 2.2 mmol/L), clinical sequelae of hypoglycaemia and hospital mortality. RESULTS: Thirty-five patients were randomised to each of the two groups. More blood glucose samples were taken per day in the intensive insulin group (16 versus 9), but the number of samples in the normoglycaemic range was 48.5%, compared with 79.8% within the target glucose range in the conventional insulin group. The median (interquartile range) blood glucose concentrations in the intensive and conventional insulin therapy groups were 5.4 (5.1-5.7) mmol/L and 7.9 (7.2-9.0) mmol/L, respectively (difference, 2.5 mmol/L; P < 0.0001). Five patients (14.3%) in the intensive insulin therapy group became hypoglycaemic versus none in the conventional insulin therapy group. There were no detected clinical sequelae of hypoglycaemia. CONCLUSION: The intensive insulin regimen was effective in achieving the target blood glucose concentration, with clear separation from the conventional insulin regimen. Although the incidence of hypoglycaemia was increased, there was no detectable harm.

AB - OBJECTIVE: To determine the safety and efficacy of an intensive insulin regimen compared with a conventional insulin regimen in general intensive care unit patients. METHODS: A phase II, randomised controlled trial was conducted in 70 critically ill patients in a closed multidisciplinary ICU of a university-affiliated tertiary hospital. We assessed patient characteristics at baseline. Trial process measures included number of blood glucose measurements per day and number in target range, type and quantity of caloric intake, patient outcome and insulin dosing. The primary outcome was the median blood glucose concentration. Secondary outcome measures were incidence of hypoglycaemia (blood glucose level < 2.2 mmol/L), clinical sequelae of hypoglycaemia and hospital mortality. RESULTS: Thirty-five patients were randomised to each of the two groups. More blood glucose samples were taken per day in the intensive insulin group (16 versus 9), but the number of samples in the normoglycaemic range was 48.5%, compared with 79.8% within the target glucose range in the conventional insulin group. The median (interquartile range) blood glucose concentrations in the intensive and conventional insulin therapy groups were 5.4 (5.1-5.7) mmol/L and 7.9 (7.2-9.0) mmol/L, respectively (difference, 2.5 mmol/L; P < 0.0001). Five patients (14.3%) in the intensive insulin therapy group became hypoglycaemic versus none in the conventional insulin therapy group. There were no detected clinical sequelae of hypoglycaemia. CONCLUSION: The intensive insulin regimen was effective in achieving the target blood glucose concentration, with clear separation from the conventional insulin regimen. Although the incidence of hypoglycaemia was increased, there was no detectable harm.

UR - http://www.scopus.com/inward/record.url?scp=33846942981&partnerID=8YFLogxK

M3 - Article

C2 - 17227263

AN - SCOPUS:33846942981

VL - 8

SP - 289

EP - 293

JO - Critical Care and Resuscitation

JF - Critical Care and Resuscitation

SN - 1441-2772

IS - 4

ER -

Mitchell I, Knight E, Gissane J, Tamhane R, Kolli R, Leditschke IA et al. A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients. Critical Care and Resuscitation. 2006 Jan 1;8(4):289-293.